Fresenius Management SE’s Supervisory Board has appointed Robert Möller (56) to the Management Board with immediate effect. Simultaneously, he will assume the role of Chairman of the Management Board of Helios Health GmbH. He takes over for Dr. Francesco de Meo (59), who is leaving the company.
Since 2022, Robert Möller has served as CEO of Helios Kliniken GmbH. He joined Helios in 2014 and was Clinic Managing Director at Helios Hanseklinikum Stralsund till 2017. He returned to Helios in 2019 after a brief absence to take over the management of numerous territories.
Möller studied human medicine at the University of Hamburg and worked as an internal medicine specialist. Following numerous medical roles and a part-time master’s degree in health care management, he transitioned to hospital administration while continuing to practise as a physician.
“Robert Möller, a physician and proven hospital manager from within the company will now move up to the Management Board. His experience is an excellent addition to the management team. With the further development of the hospital business, he will make an important contribution on the successfully chosen path to #FutureFresenius,” said Wolfgang Kirsch, Chairman of the Supervisory Board of Fresenius.
“Today, Fresenius is a company with a clear focus and clear responsibilities. We will continue to work together to execute our #FutureFresenius strategy and are well positioned to deliver. Robert Möller addresses the future of healthcare like almost no one else – with a clear focus on digitalization, sustainability and quality. At Helios, he will build on and drive the momentum we have generated so far with #FutureFresenius,” said Fresenius CEO Michael Sen.
Helios is Europe’s largest private healthcare provider, employing around 126,000 people. Helios Group in Germany is part of the Helios Health company, together with Quirónsalud in Spain and Latin America and the Eugin Group, which has a global network of reproductive clinics. With almost 24 million patients per year, the company’s total sales in 2022 are expected to be over 11.7 billion euros.
